capsul
summari
underli
respiratori
allergi
experiment
allergen
exposur
reduc
express
receptor
could
lead
reduc
suscept
ill
logic
given
mani
respiratori
virus
well
establish
caus
seriou
ill
chronic
airway
diseas
asthma
howev
asthma
respiratori
allergi
identifi
signific
risk
factor
sever
ill
case
seri
china
preliminari
report
led
us
question
whether
could
identifi
featur
allergi
andor
asthma
could
associ
potenti
reduc
ill
sever
use
angiotensinconvert
cellular
receptor
sarscov
coronaviru
higher
express
increas
vitro
suscept
sarscov
studi
examin
factor
impact
gene
express
reveal
upregul
associ
smoke
diabet
hypertens
associ
increas
ill
sever
hypothes
one
potenti
explan
unexpect
observ
asthma
allerg
diseas
may
risk
factor
sever
diseas
reduc
gene
express
airway
cell
thu
decreas
suscept
infect
test
hypothesi
examin
whether
asthma
respiratori
allergi
associ
reduc
express
airway
cell
three
differ
cohort
children
adult
three
studi
total
rna
extract
nasal
lower
airway
epitheli
brush
sampl
rnasequenc
perform
independ
studi
previous
describ
provid
detail
onlin
supplement
differenti
express
assess
use
weight
linear
mix
effect
model
limma
appropri
rnaseq
data
empir
bay
method
children
high
risk
asthma
base
upon
parent
histori
live
urban
neighborhood
enrol
prenat
follow
prospect
urban
environ
childhood
asthma
ureca
cohort
nasal
epitheli
brush
obtain
year
age
preval
asthma
assess
year
age
atop
statu
defin
allerg
sensit
trajectori
nominim
low
medium
high
previous
describ
addit
type
biomark
includ
fraction
exhal
nitric
oxid
feno
peripher
blood
eosinophil
total
ige
evalu
use
standard
method
ureca
allerg
sensit
invers
relat
express
nasal
epithelium
regardless
asthma
statu
figur
within
children
asthma
moder
allerg
sensit
fold
chang
fc
high
allerg
sensit
associ
progress
greater
reduct
compar
children
asthma
nominim
allerg
sensit
figur
express
also
significantli
invers
associ
type
biomark
supplementari
tabl
includ
number
posit
allergenspecif
ige
test
beta
coeffici
total
ige
beta
coeffici
feno
beta
coeffici
nasal
epitheli
express
beta
coeffici
express
significantli
correl
peripher
blood
eosinophil
beta
coeffici
although
male
sex
associ
increas
ill
sever
sexbas
differ
express
found
ureca
note
particip
report
nasal
corticosteroid
use
time
nasal
sampl
associ
alter
express
also
evalu
adult
particip
allerg
rhiniti
cat
without
asthma
symptom
prior
year
enrol
studi
underw
nasal
cat
allergen
challeng
nac
exposur
cat
allergen
environment
exposur
chamber
eec
previous
describ
addit
cohort
adult
particip
mild
asthma
treat
asthma
control
therapi
underw
segment
allergen
bronchoprovoc
dust
mite
ragwe
cat
previous
describ
report
respiratori
allergi
control
allergen
exposur
associ
signific
reduct
express
express
lowest
high
level
allerg
sensit
asthma
importantli
nonatop
asthma
associ
reduc
express
given
serv
receptor
find
suggest
potenti
mechan
reduc
sever
patient
respiratori
allergi
howev
like
addit
factor
beyond
express
modul
respons
allerg
individu
elucid
factor
may
also
provid
import
insight
diseas
pathogenesi
strength
studi
includ
care
phenotyp
cohort
children
adult
allergen
challeng
studi
includ
upper
lower
airway
sampl
demonstr
consist
impact
express
limit
includ
lack
clinic
inform
directli
link
express
infect
ill
sever
studi
popul
addit
data
protein
level
confirm
gene
express
data
though
previou
work
suggest
direct
associ
mrna
level
protein
level
lung
import
note
earli
data
us
suggest
higher
rate
asthma
patient
hospit
sever
ill
specifi
whether
asthma
allerg
import
differenti
relat
find
potenti
presenc
comorbid
obes
identifi
risk
factor
ill
three
studi
total
rna
extract
epitheli
brush
sampl
preserv
rlt
buffer
qiagen
md
usa
sampl
thaw
vortex
quickspun
supernat
transfer
fresh
tube
sampl
spun
qiashredd
column
qiagen
extract
use
rneasi
mini
kit
qiagen
ul
elut
volum
follow
manufactur
protocol
cat
allergi
upper
airway
challeng
studi
sequenc
librari
construct
total
rna
use
truseq
rna
sampl
prepar
kit
illumina
ureca
adult
asthma
studi
sequenc
librari
construct
total
rna
use
smartseq
ultra
low
input
rna
kit
takara
studi
librari
cluster
onto
flowcel
use
cbot
amplif
system
hiseq
sr
cluster
kit
illumina
singleread
sequenc
carri
sequenc
illumina
use
hiseq
sb
kit
gener
read
target
approxim
million
read
per
sampl
sampl
studi
process
sequenc
independ
read
process
use
workflow
manag
galaxi
platform
read
trim
base
end
trim
end
base
call
minimum
qualiti
score
least
galaxi
fastq
trimmer
tool
fastqmcf
use
remov
remain
adapt
sequenc
align
trim
read
use
star
align
refer
genom
gene
annot
ensembl
releas
gene
count
gener
use
htseqcount
qualiti
control
sampl
kept
count
million
percent
read
align
median
cv
coverag
gene
filter
includ
trim
mean
valu
tmm
normal
count
least
least
librari
classifi
protein
code
use
biomart
count
transform
count
per
million
along
observ
level
weight
use
voomwithqualityweight
limma
r
packag
creat
weight
gene
express
matrix
suitabl
downstream
analys
differenti
express
assess
independ
dataset
use
weight
linear
mix
effect
model
limma
appropri
rnaseq
data
empir
bay
method
mixedeffect
linear
regress
model
use
includ
relev
clinic
technic
variabl
ureca
cytolog
determin
cell
percentag
brush
clinic
site
upper
airway
challeng
studi
process
batch
adult
asthma
studi
fix
effect
includ
random
effect
particip
airway
challeng
studi
pvalu
consid
statist
signific
